Curology

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Mesoblast (ASX: MSB) clears key treatment milestone ahead of mid-2027 back pain trial readout

Santos (ASX: STO) warns Australia’s 20% gas reservation rule could undermine GLNG economics

Russian missiles strike Kyiv as attacks injure 17 in Zaporizhzhia and Kharkiv

Regis Resources (ASX: RRL) drops Vault Minerals bid, letting Genesis Minerals’s A$5.6bn offer proceed

DayPrimeRx is a dual-action innovation from Curology that merges clinical acne treatment with a primer designed for all-day cosmetic wear.

Curology launches DayPrimeRx: Can a prescription acne primer change how skincare works during the day?

Curology’s DayPrimeRx combines prescription acne care with a makeup primer in one product. Discover how this innovation could redefine daytime skincare in 2025.

μFR system
αvβ6-integrin
α4β7 integrin
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures

October 19, 2025